334 related articles for article (PubMed ID: 29892299)
1. IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells.
Abel AM; Tiwari AA; Gerbec ZJ; Siebert JR; Yang C; Schloemer NJ; Dixon KJ; Thakar MS; Malarkannan S
Front Immunol; 2018; 9():1168. PubMed ID: 29892299
[TBL] [Abstract][Full Text] [Related]
2. Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes.
Awasthi A; Samarakoon A; Chu H; Kamalakannan R; Quilliam LA; Chrzanowska-Wodnicka M; White GC; Malarkannan S
J Exp Med; 2010 Aug; 207(9):1923-38. PubMed ID: 20733035
[TBL] [Abstract][Full Text] [Related]
3. MyD88 is an essential regulator of NK cell-mediated clearance of MCMV infection.
Dixon KJ; Siebert JR; Wang D; Abel AM; Johnson KE; Riese MJ; Terhune SS; Tarakanova VL; Thakar MS; Malarkannan S
Mol Immunol; 2021 Sep; 137():94-104. PubMed ID: 34242922
[TBL] [Abstract][Full Text] [Related]
4. IQ motif-containing GTPase-activating protein 1 is essential for the optimal maintenance of lung ILC2s.
Tayama S; Okuyama Y; Phung HT; Asao A; Kobayashi S; Musha T; Machiyama T; Sakurai T; Zhang C; Ushio-Fukai M; Kawabe T; So T; Ishii N
Int Immunol; 2020 Apr; 32(4):233-241. PubMed ID: 31819988
[TBL] [Abstract][Full Text] [Related]
5. Natural killer group 2D receptor and its ligands in cancer immune escape.
Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
[TBL] [Abstract][Full Text] [Related]
6. Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice.
Al Dulaimi D; Klibi J; Olivo Pimentel V; Parietti V; Allez M; Toubert A; Benlagha K
Front Immunol; 2018; 9():1052. PubMed ID: 29868013
[TBL] [Abstract][Full Text] [Related]
7. Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.
Zhu S; Phatarpekar PV; Denman CJ; Senyukov VV; Somanchi SS; Nguyen-Jackson HT; Mace EM; Freeman AF; Watowich SS; Orange JS; Holland SM; Lee DA
Blood; 2014 Jul; 124(3):403-11. PubMed ID: 24891320
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection.
Muntasell A; Magri G; Pende D; Angulo A; López-Botet M
Blood; 2010 Jun; 115(25):5170-9. PubMed ID: 20393128
[TBL] [Abstract][Full Text] [Related]
9. Activation Receptor-Dependent IFN-γ Production by NK Cells Is Controlled by Transcription, Translation, and the Proteasome.
Piersma SJ; Pak-Wittel MA; Lin A; Plougastel-Douglas B; Yokoyama WM
J Immunol; 2019 Oct; 203(7):1981-1988. PubMed ID: 31444264
[TBL] [Abstract][Full Text] [Related]
10. PI3K p85 β regulatory subunit deficiency does not affect NK cell differentiation and increases NKG2D-mediated activation.
Rojas JM; Spada R; Sanz-Ortega L; Morillas L; Mejías R; Mulens-Arias V; Pérez-Yagüe S; Barber DF
J Leukoc Biol; 2016 Dec; 100(6):1285-1296. PubMed ID: 27381007
[TBL] [Abstract][Full Text] [Related]
11. IQGAP1 involvement in MTOC and granule polarization in NK-cell cytotoxicity.
Kanwar N; Wilkins JA
Eur J Immunol; 2011 Sep; 41(9):2763-73. PubMed ID: 21681737
[TBL] [Abstract][Full Text] [Related]
12. Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells.
Zanetti SR; Ziblat A; Torres NI; Zwirner NW; Bouzat C
J Biol Chem; 2016 Aug; 291(32):16541-52. PubMed ID: 27284006
[TBL] [Abstract][Full Text] [Related]
13. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease.
Wortham BW; Eppert BL; Motz GT; Flury JL; Orozco-Levi M; Hoebe K; Panos RJ; Maxfield M; Glasser SW; Senft AP; Raulet DH; Borchers MT
J Immunol; 2012 May; 188(9):4468-75. PubMed ID: 22467655
[TBL] [Abstract][Full Text] [Related]
14. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
15. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation.
Malarkannan S; Regunathan J; Chu H; Kutlesa S; Chen Y; Zeng H; Wen R; Wang D
J Immunol; 2007 Sep; 179(6):3752-62. PubMed ID: 17785812
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
Kopp HG; Placke T; Salih HR
Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
[TBL] [Abstract][Full Text] [Related]
17. NKG2D: A versatile player in the immune system.
Jelenčić V; Lenartić M; Wensveen FM; Polić B
Immunol Lett; 2017 Sep; 189():48-53. PubMed ID: 28414183
[TBL] [Abstract][Full Text] [Related]
18. Loss of NKG2D in murine NK cells leads to increased perforin production upon long-term stimulation with IL-2.
Prinz D; Klein K; List J; Knab VM; Menzl I; Leidenfrost N; Heller G; Polić B; Putz EM; Witalisz-Siepracka A; Sexl V; Gotthardt D
Eur J Immunol; 2020 Jun; 50(6):880-890. PubMed ID: 32052406
[TBL] [Abstract][Full Text] [Related]
19. An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia.
Steinbacher J; Baltz-Ghahremanpour K; Schmiedel BJ; Steinle A; Jung G; Kübler A; André MC; Grosse-Hovest L; Salih HR
Int J Cancer; 2015 Mar; 136(5):1073-84. PubMed ID: 25046567
[TBL] [Abstract][Full Text] [Related]
20. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
